Results

Total Results: 839 records

Showing results for "phase".

321. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or … Liraglutide is under investigation for obesity treatment in a four-part, phase III clinical trial ( … People with type 2 diabetes achieve 6% weight loss with liraglutide 3 mg in phase 3a obesity trial … Novo Nordisk reports 8% weight loss in phase 3a obesity trial with liraglutide 3 mg.

322. Research White Paper: Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-outcome-measure-harmonization-depression.pdf
     November 01, 2020 - The next phase of this project will focus collection of the baseline and follow-up PHQ-9s, as well as … useful to guide future implementations of the harmonized measures. 12 Next Steps The next phase

323. labor-dystocia-protocol-amended-160728 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-dystocia_research-protocol.pdf
     July 28, 2016 - "[tiab] OR "Uterine Atony"[tiab] OR "inefficient uterine action"[tiab] OR "prolonged deceleration phase

324. Crosscutting-Horizon-Scan-High-Impact-1412 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists three topics for which (1) preliminary or published phase III data were … medication regimens tested in clinical trials has been implicated as a significant reason that many phase … Failure to determine these thresholds during Phase 2 is believed to be one of the main reasons for … Phase 3 failures.”30 One phase IV clinical trial is ongoing to evaluate the cost and perception of

325. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary mid- or late-phase data for … topics in this priority area were eligible for consideration for high-impact potential because no phase … indication, and Janssen plans to also apply for breakthrough therapy status.38,39 Janssen has two new phase … that all available scopolamine formulations had some degree of antidepressant efficacy.75 In the phase

326. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
     August 01, 2020 - week stabilization, 2 week taper) Retention: # of SMM (standard medical management) visits Phase … 1: 4.4 (1.5) ODC vs 4.5 (1.5) SMM alone (z=1.24, p=0.39) Phase 2: 14.1 (4.4) ODC vs 13.9 … 1 (n=2) or Phase 2 (n=3) taper. … KQ3: A history of ever using heroin was associated with lower Phase 2 success rates while taking … buprenorphine- naloxone Chronic pain at baseline was not related to outcomes either in Phase 1 or

327. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
     October 05, 2018 - 159463) 70 single blind method/ (27137) 71 clinical trial/ (553719) 72 clinical trial, phase … i.pt. (20676) 73 clinical trial, phase ii.pt. (33325) 74 clinical trial, phase iii.pt. (15646 … ) 75 clinical trial, phase iv.pt. (1673) 76 controlled clinical trial.pt. (100423) 77

328. final Fibromyalgia CER protocol_3-31-14 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fibromyalgia_research-protocol.pdf
     April 03, 2014 - 38          clinical  trial/  (504861)   39          clinical  trial,  phase …  (16220)   40          clinical  trial,  phase  ii.pt. …  (26918)   41          clinical  trial,  phase  iii.pt. …  (10181)   42          clinical  trial,  phase  iv.pt.

329. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary phase III data for drugs were … microbiota therapy for irritable bowel disease that are in clinical trials but have not yet reported phase

330. Evidence Summary CER 208 Treatment For Bipolar Disorder In Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
     August 01, 2018 - Conclusion We found no high or moderate-strength evidence for any intervention to effectively treat any phase … The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: A phase … Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase

331. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/module_ii1.ppt
     June 01, 2011 - research activities As a result, it is important to develop specific strategies at each EHC Program phase

332. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/module_i1.ppt
     May 29, 2025 - Slide 1 Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators Numeric

333. Gout-managment-protocol-141103 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
     November 03, 2014 - The acute phase is self-limited and characterized by recurrent attacks of synovitis (articular inflammation … 1ß-inhibitory anti- inflammatory agents currently approved for treatment of rheumatoid arthritis and in Phase

334. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
     February 01, 2012 - also excluded patients who did not meet minimum response criteria or were nonadherent during a run-in phase … before the double-blind treatment phase.

335. S44 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - ORIGINAL ARTICLE Designed Delays Versus Rigorous Pragmatic Trials Lower Carat Gold Standards Can Produce Relevant Drug Evaluations Malcolm Maclure, ScD,* Bruce Carleton, PharmD,† and Sebastian Schneeweiss, MD, ScD‡§¶ Background: Centralized administrative databases enable low-cost pragmatic randomized trials (PRTs) …

336. Innovations in Stakeholder Engagement Conference Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/innovations_in_stakeholder_engagement_conference_summary2.pdf
     October 01, 2011 - Innovations in Stakeholder Engagement Conference Summary Innovations in Stakeholder Engagement Conference Summary 2 AHRQ Community Forum Overview of Types of Online Collaborative Platforms Chris Haller, Founder and CEO, Urban Interactive Studios Online collaborative platforms provide an avenue for individua…

337. Medical Therapies for Children With Autism Spectrum Disorder—An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
     May 01, 2017 - KQ4: What is the evidence that effects measured at the end of the treatment phase predict long-term … investigative team also scanned the reference lists of studies included after the full-text review phase … atomoxetine No serious adverse events reported; most harms attenuated over open label extension phase

338. Ced-Appendix-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-appendix-3.xlsx
     June 24, 2022 - NICE_cancer Data Use data from a registry, from ongoing studies (for example, further follow-up of Phase … II and III trials, or Phase IV or pharmacovigilance studies), or set up new data collection. … NICE_cancer Data_source Use data from a registry, from ongoing studies (for example, further follow-up of Phase … II and III trials, or Phase IV or pharmacovigilance studies), or set up new data collection.

339. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
     June 01, 2010 - While one Phase 2 trial and one Phase 3 trial were both able to show a reduction in bleeding with the … A case in point is the recently published Novo Nordisk sponsored Phase 2 cardiac trial (F7CARD-1610) … The pooling of dose-escalation studies with Phase 2 or Phase 3 studies in the efficacy analyses is a … non-parallel safety studies (Mayer 2005b31 and Mayer 200632) are inappropriately combined with the Phase … Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial. .Neurocrit

340. Antipsychotics-Children-Surveillance-150120 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
     October 01, 2014 - A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit … A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit … We found one-long term (72 weeks) RCT reporting on the maintenance phase (Findling, 2012). … One completed suicide occurred during the OLE phase. … A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit